176 related articles for article (PubMed ID: 23761568)
1. Small cell gall bladder carcinoma complicated by syndrome of inappropriate secretion of antidiuretic hormone (SIADH) treated with mozavaptan.
Tamura T; Takeuchi K
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23761568
[TBL] [Abstract][Full Text] [Related]
2. Esophageal small-cell carcinoma with syndrome of inappropriate secretion of antidiuretic hormone.
Ando T; Hosokawa A; Yamawaki H; Hasumoto Y; Kajiura S; Itaya Y; Ueda A; Suzuki N; Nishikawa J; Fujinami H; Miyazaki T; Ogawa K; Sugiyama T
Intern Med; 2011; 50(10):1099-103. PubMed ID: 21576835
[TBL] [Abstract][Full Text] [Related]
3. Clinical implication of the antidiuretic hormone (ADH) receptor antagonist mozavaptan hydrochloride in patients with ectopic ADH syndrome.
; Yamaguchi K; Shijubo N; Kodama T; Mori K; Sugiura T; Kuriyama T; Kawahara M; Shinkai T; Iguchi H; Sakurai M
Jpn J Clin Oncol; 2011 Jan; 41(1):148-52. PubMed ID: 21087977
[TBL] [Abstract][Full Text] [Related]
4. Pure small cell recurrent prostate cancer developing syndrome of inappropriate antidiuretic hormone secretion.
Peverelli G; Grassi P
Tumori; 2017 Nov; 103(Suppl. 1):e56-e59. PubMed ID: 28623637
[TBL] [Abstract][Full Text] [Related]
5. Tolvaptan is successful in treating inappropriate antidiuretic hormone secretion in infants.
Marx-Berger D; Milford DV; Bandhakavi M; Van't Hoff W; Kleta R; Dattani M; Bockenhauer D
Acta Paediatr; 2016 Jul; 105(7):e334-7. PubMed ID: 27028950
[TBL] [Abstract][Full Text] [Related]
6. Syndrome of inappropriate secretion of antidiuretic hormone in traumatic brain injury: when tolvaptan becomes a life saving drug.
Graziani G; Cucchiari D; Aroldi A; Angelini C; Gaetani P; Selmi C
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):510-2. PubMed ID: 22323742
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
Jamookeeah C; Robinson P; O'Reilly K; Lundberg J; Gisby M; Ländin M; Skov J; Trueman D
BMC Endocr Disord; 2016 May; 16(1):22. PubMed ID: 27184496
[TBL] [Abstract][Full Text] [Related]
8. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
Mali P; Muduganti SR; Mujibur R; Murali N
WMJ; 2015 Apr; 114(2):66-8. PubMed ID: 26756059
[TBL] [Abstract][Full Text] [Related]
9. [Syndrome of inappropriate ADH secretion (SIADH) in small-cell bronchus carcinoma].
von Rohr A; Cerny T; Joss RA; Brunner KW
Schweiz Med Wochenschr; 1991 Sep; 121(36):1271-82. PubMed ID: 1656520
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of long-term tolvaptan treatment in a patient with SCLC and SIADH.
Bordi P; Tiseo M; Buti S; Regolisti G; Ardizzoni A
Tumori; 2015 Apr; 101(2):e51-3. PubMed ID: 25702667
[TBL] [Abstract][Full Text] [Related]
11. [Symptomatic therapy of SIADH in small cell lung cancer by tolvaptan].
Schnaiter A; Hiddemann W
Dtsch Med Wochenschr; 2014 Oct; 139(41):2077-9. PubMed ID: 25268207
[TBL] [Abstract][Full Text] [Related]
12. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
[TBL] [Abstract][Full Text] [Related]
13. Dual paraneoplastic syndromes: small cell lung carcinoma-related oncogenic osteomalacia, and syndrome of inappropriate antidiuretic hormone secretion: report of a case and review of the literature.
Tantisattamo E; Ng RC
Hawaii Med J; 2011 Jul; 70(7):139-43. PubMed ID: 21886301
[TBL] [Abstract][Full Text] [Related]
14. Real-World, Non-Interventional, Retrospective Study (SAMPLE) of Tolvaptan in Patients with Hyponatraemia Secondary to the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Pose-Reino A; Runkle de la Vega I; de Jong-Laird A; Kabra M; Lindner U
Adv Ther; 2021 Feb; 38(2):1055-1067. PubMed ID: 33306187
[TBL] [Abstract][Full Text] [Related]
15. Syndrome of inappropriate antidiuretic hormone secretion and ectopic ACTH production in small cell lung carcinoma.
Müssig K; Horger M; Häring HU; Wehrmann M
Lung Cancer; 2007 Jul; 57(1):120-2. PubMed ID: 17418447
[TBL] [Abstract][Full Text] [Related]
16. Uric acid levels with tolvaptan treatment for syndrome of inappropriate antidiuretic hormone secretion.
Nagamine T
Endocrine; 2024 Mar; 83(3):826-827. PubMed ID: 37982946
[No Abstract] [Full Text] [Related]
17. Low-dose tolvaptan for the treatment of hyponatremia in the syndrome of inappropriate ADH secretion (SIADH).
Harbeck B; Lindner U; Haas CS
Endocrine; 2016 Sep; 53(3):872-3. PubMed ID: 26961548
[No Abstract] [Full Text] [Related]
18. The syndrome of inappropriate antidiuretic hormone: current and future management options.
Sherlock M; Thompson CJ
Eur J Endocrinol; 2010 Jun; 162 Suppl 1():S13-8. PubMed ID: 20164215
[TBL] [Abstract][Full Text] [Related]
19. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) due to bortezomib in a case of light chain multiple mieloma. Treatment with tolvaptan.
Carreño A; Hernández B; Mayoralas Á; Calle C
Nefrologia; 2017; 37(5):558-559. PubMed ID: 28946972
[No Abstract] [Full Text] [Related]
20. Small cell carcinoma of the cervix complicated by syndrome of inappropriate antidiuretic hormone secretion: a case report.
Zhao CF; Zhao SF; Du ZQ
J Int Med Res; 2021 Feb; 49(2):300060520985657. PubMed ID: 33596689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
